Your browser version may not work well with NCBI's Web applications. More information here...
1: Cancer Res. 2008 Jan 15;68(2):339-42.Click here to read Links

Cannabinoids for cancer treatment: progress and promise.

Chemoprevention Program, Paul P. Carbone Comprehensive Cancer Center and Department of Dermatology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53706, USA.

Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer. Here, we review recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy.

PMID: 18199524 [PubMed - indexed for MEDLINE]